Moderna, Inc.
(NASDAQ : MRNA)

( )
MRNA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -4.08%61.590.0%$953.82m
GILDGilead Sciences, Inc. -1.14%76.061.0%$768.72m
AMGNAmgen, Inc. 8.17%255.121.3%$748.85m
REGNRegeneron Pharmaceuticals, Inc. -2.32%609.172.5%$678.56m
NVAXNovavax, Inc. -4.38%79.70102.0%$606.94m
BIIBBiogen, Inc. -1.04%264.771.6%$543.38m
VRTXVertex Pharmaceuticals, Inc. -1.39%286.281.9%$524.18m
ILMNIllumina, Inc. -0.49%368.553.5%$308.59m
ALXNAlexion Pharmaceuticals, Inc. 0.13%112.392.0%$229.11m
BMRNBioMarin Pharmaceutical, Inc. 2.03%125.844.3%$214.73m
SGENSeattle Genetics, Inc. -1.41%167.526.1%$201.85m
SRNESorrento Therapeutics, Inc. 10.35%6.931.8%$186.93m
SRPTSarepta Therapeutics, Inc. 3.33%165.6813.9%$168.66m
INCYIncyte Corp. -1.27%102.652.5%$160.00m
IMMUImmunomedics, Inc. 4.15%36.9111.0%$154.32m

Company Profile

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.